Skip to main content
. 2022 Feb 28;47(3):419–429. doi: 10.1007/s13318-021-00745-6

Fig. 4.

Fig. 4

Mean (SD) plasma concentrations of abrocitinib and metabolites prior to dosing on Days 1–4, and at 24 h following dosing on Day 4 following 4 days of abrocitinib 200 mg once-daily dosing to assess the steady state of abrocitinib M1, M2, and M4